BOLD FY 2025 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$64M

Net Income

-$58M

EPS (Diluted)

$-2.60

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$47M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$157M

Total Liabilities

$58M

Stockholders' Equity

$99M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$64M	-$73M	+13.3%
Net Income	-$58M	-$65M	+11.0%